Bio-Techne Q4 FY2021 revenue up 47% to $259M; adjusted EPS $1.87 vs $1.00 YoY

BIO-TECHNE Corp

2021-FY EPS reported $3.47 revenue$931,032,000

Q4 organic revenue rose 39% to $259.0M; GAAP EPS $0.37, adjusted EPS $1.87 (vs $1.00 prior year).
Full-year revenue $931.0M, adjusted EPS $6.75, record operating cash flow $352M.
Protein Sciences organic +46%, Diagnostics & Genomics +22%; adj. operating margin 38.5% vs 31.1%.
Board declares $0.32/share quarterly dividend, payable Aug 27, 2021 to holders of record Aug 16, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.